What does CUSIP 28036F105 represent in this 13F holders report?

CUSIP 28036F105 is the security identifier for EWTX - Edgewise Therapeutics, Inc. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held EWTX - Edgewise Therapeutics, Inc. - COMMON STOCK in Q3 2023?

84 institutional investors reported EWTX - Edgewise Therapeutics, Inc. - COMMON STOCK for Q3 2023. Use the holders table for investor-level position and value details.

Edgewise Therapeutics, Inc. - COMMON STOCK (EWTX)

CUSIP: 28036F105

Q3 2023 13F Holders as of 30 Sep 2023

Security type / class: Equity / COMMON STOCK
Total 13F shares: 68,438,296
Total 13F value: $392,172,292
Share change: -905,995
Put/Call ratio: 27%
SEC-reported price per share: $5.73
Number of holders: 84
Value change: -$8,215,044
Number of buys: 50
Number of sells: 34
Shares outstanding: 107,880,000

Security key

28036F105

Report period

Q3 2023

Institutions

Top holders

EWTX full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2026 Edgewise Therapeutics, Inc. SEC filings Edgewise Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 28036F105

Newer quarter: Q3 2026

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of EWTX - Edgewise Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Novo Holdings A/S

Disclosed value leader

ORBIMED ADVISORS LLC

Comparable rows

0/15

Latest evidence

30 Jun 2023

3/4/5 13F Highest disclosed value: $112,895,614 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ORBIMED ADVISORS LLC has the largest disclosed position value at $112.9M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.

Disclosed position value Top 5

Novo Holdings A/S $95.78M

ORBIMED ADVISORS LLC $112.9M

VIKING GLOBAL INVESTORS LP $46.06M

DEERFIELD MANAGEMENT COMPANY, L.P. $30.48M

EcoR1 Capital, LLC $27.07M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Novo Holdings A/S	3/4/5 13F 10%+ Owner · Company 3/4/5 13F	— denominator unverified	$95,781,722 6,071,703 shares	—	14 Sep 2022
ORBIMED ADVISORS LLC	13F Company 13F	— denominator unverified	$112,895,614 14,567,176 shares	—	30 Jun 2023
VIKING GLOBAL INVESTORS LP	13F Company 13F	— denominator unverified	$46,060,273 5,943,261 shares	—	30 Jun 2023
DEERFIELD MANAGEMENT COMPANY, L.P.	13F Company 13F	— denominator unverified	$30,481,812 3,933,137 shares	—	30 Jun 2023
EcoR1 Capital, LLC	13F Company 13F	— denominator unverified	$27,072,254 3,493,194 shares	—	30 Jun 2023
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$24,289,803 3,134,168 shares	—	30 Jun 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

68,438,296

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders

Q3 2023 holders

Holder diff

-10

Investor	Q2 2023 Shares	Q3 2023 Shares	Share Diff	Share Chg %	Q2 2023 value	Q3 2023 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend